Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−23.82 M EUR
811.31 K EUR
51.09 M
About Mainz Biomed N.V.
Sector
Industry
CEO
Guido Baechler
Website
Headquarters
Mainz
Founded
2021
ISIN
NL0015000LC2
FIGI
BBG013CRNFM6
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4TO is 0.21 EUR — it has decreased by −11.67% in the past 24 hours. Watch MAINZ BIOMED N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange MAINZ BIOMED N.V. stocks are traded under the ticker 4TO.
4TO stock has risen by 6.00% compared to the previous week, the month change is a −11.85% fall, over the last year MAINZ BIOMED N.V. has showed a −79.00% decrease.
4TO stock is 38.26% volatile and has beta coefficient of 0.56. Track MAINZ BIOMED N.V. stock price on the chart and check out the list of the most volatile stocks — is MAINZ BIOMED N.V. there?
Today MAINZ BIOMED N.V. has the market capitalization of 15.54 M, it has increased by 137.87% over the last week.
Yes, you can track MAINZ BIOMED N.V. financials in yearly and quarterly reports right on TradingView.
MAINZ BIOMED N.V. is going to release the next earnings report on Nov 29, 2024. Keep track of upcoming events with our Earnings Calendar.
4TO earnings for the last quarter are −0.46 EUR per share, whereas the estimation was −0.14 EUR resulting in a −226.67% surprise. The estimated earnings for the next quarter are −0.10 EUR per share. See more details about MAINZ BIOMED N.V. earnings.
MAINZ BIOMED N.V. revenue for the last quarter amounts to 466.80 K EUR, despite the estimated figure of 373.44 K EUR. In the next quarter, revenue is expected to reach 269.44 K EUR.
No, 4TO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 4TO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MAINZ BIOMED N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MAINZ BIOMED N.V. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MAINZ BIOMED N.V. stock shows the sell signal. See more of MAINZ BIOMED N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.